1
|
Early psoriatic arthritis: the clinical spectrum.
|
J Rheumatol
|
2007
|
1.79
|
2
|
Platelet reactivity and disease activity in subjects with psoriatic arthritis.
|
J Rheumatol
|
2011
|
1.51
|
3
|
Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers.
|
Ann Rheum Dis
|
2013
|
1.07
|
4
|
Obesity and the prediction of minimal disease activity: a prospective study in psoriatic arthritis.
|
Arthritis Care Res (Hoboken)
|
2013
|
1.05
|
5
|
Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs.
|
Arterioscler Thromb Vasc Biol
|
2011
|
1.02
|
6
|
Nail and distal interphalangeal joint in psoriatic arthritis.
|
J Rheumatol
|
2006
|
1.00
|
7
|
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs.
|
Clin Rheumatol
|
2010
|
0.97
|
8
|
Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management.
|
Rheumatology (Oxford)
|
2012
|
0.96
|
9
|
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate.
|
Clin Rheumatol
|
2007
|
0.94
|
10
|
Hepatic steatosis and disease activity in subjects with psoriatic arthritis receiving tumor necrosis factor-α blockers.
|
J Rheumatol
|
2012
|
0.91
|
11
|
Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study.
|
Arthritis Res Ther
|
2012
|
0.90
|
12
|
Enteropathic spondyloarthritis: from diagnosis to treatment.
|
Clin Dev Immunol
|
2013
|
0.87
|
13
|
Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.
|
Semin Thromb Hemost
|
2012
|
0.86
|
14
|
Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases.
|
Arthritis Care Res (Hoboken)
|
2012
|
0.85
|
15
|
Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.
|
Clin Rheumatol
|
2013
|
0.85
|
16
|
Alcohol dosing and the heart: updating clinical evidence.
|
Semin Thromb Hemost
|
2011
|
0.84
|
17
|
Prevalence of thyroid autoimmunity in patients with spondyloarthropathies.
|
J Rheumatol
|
2011
|
0.82
|
18
|
Extra-articular manifestations in psoriatic arthritis patients.
|
Clin Rheumatol
|
2014
|
0.82
|
19
|
Ultrasonography of peripheral entheses in the diagnosis and understanding of diffuse idiopathic skeletal hyperostosis (DISH).
|
Rheumatol Int
|
2014
|
0.82
|
20
|
Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies.
|
Ann Med
|
2014
|
0.81
|
21
|
TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis.
|
Intern Emerg Med
|
2011
|
0.81
|
22
|
Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis--effect of different treatments.
|
J Rheumatol
|
2014
|
0.80
|
23
|
Discovertebral erosions in patients with enteropathic spondyloarthritis.
|
J Rheumatol
|
2012
|
0.78
|
24
|
Magnetic resonance imaging of nail unit in psoriatic arthritis.
|
J Rheumatol Suppl
|
2009
|
0.78
|
25
|
Early psoriatic arthritis.
|
J Rheumatol Suppl
|
2009
|
0.76
|
26
|
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer.
|
J Clin Rheumatol
|
2011
|
0.75
|
27
|
A rare case of acute compartment syndrome after saphenectomy.
|
World J Clin Cases
|
2013
|
0.75
|
28
|
Effectiveness of a rehabilitative programme in improving fatigue and function in rheumatoid arthritis patients treated with biologics: a pilot study.
|
Clin Exp Rheumatol
|
2013
|
0.75
|
29
|
Assessing joint involvement in haemophilia by clinical rheumatologic scores. A pilot study on similarities with subjects with psoriatic arthritis.
|
Clin Rheumatol
|
2011
|
0.75
|